Semin Thromb Hemost 2017; 43(07): 732-741
DOI: 10.1055/s-0037-1603447
Review Article
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Hemostatic Complications in Hepatobiliary Surgery

Sarah Bos
1   Department of Internal Medicine, University of Groningen, University Medical Center, Groningen, The Netherlands
,
William Bernal
2   Institute of Liver Studies, King's College Hospital, London, United Kingdom
,
Robert J. Porte
3   Department of Surgery, University of Groningen, University Medical Center, Groningen, The Netherlands
,
Ton Lisman
4   Surgical Research Laboratory, University of Groningen, University Medical Center, Groningen, The Netherlands
› Author Affiliations
Further Information

Publication History

Publication Date:
13 June 2017 (online)

Abstract

Hepatobiliary surgery is a well-known risk factor for thrombotic complications but is also associated with substantial perioperative blood loss. Given the central role of the liver in hemostasis, hepatobiliary surgery is frequently accompanied by complex changes in the hemostatic system. Increasing knowledge of these changes has resulted in an improved understanding of the etiology of some of the hemostatic complications. In the early postoperative period a prolongation of conventional coagulation test times, such as the prothrombin time, is frequently seen. Together with a decreased platelet count, this suggests a hypocoagulable state. The concomitant decline of anticoagulant factors and development of a von Willebrand factor/ADAMTS13 (a disintegrin and metalloproteinase with a thrombospondin type 1 motif, member 13) imbalance, however, suggest a hypercoagulable state, potentially contributing to the risk of thromboembolism. Postoperative thromboprophylaxis should be initiated early to avoid thrombosis, and intensified prophylaxis might benefit high-risk patients. The risk of hemorrhagic complications during hepatobiliary surgery has diminished over time, mainly due to improved surgical and anesthesiological techniques. However, bleeding can still be profound in individual patients and is difficult to predict using (global) hemostasis tests. A restrictive transfusion and fluid infusion policy to maintain a low central venous pressure is crucial in prevention of perioperative bleeding. However, when active bleeding occurs, proactive prohemostatic management is required.

Note

The authors received no financial support, and they have no conflict of interest to disclose.


 
  • References

  • 1 Lisman T, Leebeek FWG, de Groot PG. Haemostatic abnormalities in patients with liver disease. J Hepatol 2002; 37 (02) 280-287
  • 2 Romano F, Garancini M, Uggeri F. , et al. Bleeding in hepatic surgery: Sorting through methods to prevent it. HPB Surg 2012; 2012: 169351
  • 3 Bismuth H, Castaing D, Garden OJ. Major hepatic resection under total vascular exclusion. Ann Surg 1989; 210 (01) 13-19
  • 4 de Boer MT, Molenaar IQ, Hendriks HGD, Slooff MJH, Porte RJ. Minimizing blood loss in liver transplantation: progress through research and evolution of techniques. Dig Surg 2005; 22 (04) 265-275
  • 5 Westerkamp AC, Lisman T, Porte RJ. How to minimize blood loss during liver surgery in patients with cirrhosis. HPB (Oxford) 2009; 11 (06) 453-458
  • 6 Reddy SK, Turley RS, Barbas AS. , et al. Post-operative pharmacologic thromboprophylaxis after major hepatectomy: does peripheral venous thromboembolism prevention outweigh bleeding risks?. J Gastrointest Surg 2011; 15 (09) 1602-1610
  • 7 Davidson BR, Gibson M, Dick R, Burroughs A, Rolles K. Incidence, risk factors, management, and outcome of portal vein abnormalities at orthotopic liver transplantation. Transplantation 1994; 57 (08) 1174-1177
  • 8 Ghabril M, Agarwal S, Lacerda M, Chalasani N, Kwo P, Tector AJ. Portal vein thrombosis is a risk factor for poor early outcomes after liver transplantation: analysis of risk factors and outcomes for portal vein thrombosis in waitlisted patients. Transplantation 2016; 100 (01) 126-133
  • 9 Lisman T, Porte RJ. Value of preoperative hemostasis testing in patients with liver disease for perioperative hemostatic management. Anesthesiology 2017; 126 (02) 338-344
  • 10 Hugenholtz GCG, Northup PG, Porte RJ, Lisman T. Is there a rationale for treatment of chronic liver disease with antithrombotic therapy?. Blood Rev 2015; 29 (02) 127-136
  • 11 Tripodi A, Mannucci PM. The coagulopathy of chronic liver disease. N Engl J Med 2011; 365 (02) 147-156
  • 12 Tripodi A. Liver disease and hemostatic (Dys)function. Semin Thromb Hemost 2015; 41 (05) 462-467
  • 13 Lisman T, Porte RJ. Rebalanced hemostasis in patients with liver disease: evidence and clinical consequences. Blood 2010; 116 (06) 878-885
  • 14 Feltracco P, Barbieri S, Cillo U, Zanus G, Senzolo M, Ori C. Perioperative thrombotic complications in liver transplantation. World J Gastroenterol 2015; 21 (26) 8004-8013
  • 15 Hartmann M, Szalai C, Saner FH. Hemostasis in liver transplantation: Pathophysiology, monitoring, and treatment. World J Gastroenterol 2016; 22 (04) 1541-1550
  • 16 Yoshizumi T, Itoh S, Imai D. , et al. Impact of platelets and serotonin on liver regeneration after living donor hepatectomy. Transplant Proc 2015; 47 (03) 683-685
  • 17 Lesurtel M, Raptis DA, Melloul E. , et al. Low platelet counts after liver transplantation predict early posttransplant survival: the 60-5 criterion. Liver Transpl 2014; 20 (02) 147-155
  • 18 Richards EM, Alexander GJ, Calne RY, Baglin TP. Thrombocytopenia following liver transplantation is associated with platelet consumption and thrombin generation. Br J Haematol 1997; 98 (02) 315-321
  • 19 Lisman T, Bongers TN, Adelmeijer J. , et al. Elevated levels of von Willebrand factor in cirrhosis support platelet adhesion despite reduced functional capacity. Hepatology 2006; 44 (01) 53-61
  • 20 Hugenholtz GCG, Adelmeijer J, Meijers JCM, Porte RJ, Stravitz RT, Lisman T. An unbalance between von Willebrand factor and ADAMTS13 in acute liver failure: implications for hemostasis and clinical outcome. Hepatology 2013; 58 (02) 752-761
  • 21 Kobayashi T, Wada H, Usui M. , et al. Decreased ADAMTS13 levels in patients after living donor liver transplantation. Thromb Res 2009; 124 (05) 541-545
  • 22 Groeneveld DJ, Alkozai EM, Adelmeijer J, Porte RJ, Lisman T. Balance between von Willebrand factor and ADAMTS13 following major partial hepatectomy. Br J Surg 2016; 103 (06) 735-743
  • 23 Pereboom ITA, Adelmeijer J, van Leeuwen Y, Hendriks HGD, Porte RJ, Lisman T. Development of a severe von Willebrand factor/ADAMTS13 dysbalance during orthotopic liver transplantation. Am J Transplant 2009; 9 (05) 1189-1196
  • 24 Kobayashi S, Yokoyama Y, Matsushita T. , et al. Increased von Willebrand factor to ADAMTS13 ratio as a predictor of thrombotic complications following a major hepatectomy. Arch Surg 2012; 147 (10) 909-917
  • 25 Chion CKNK, Doggen CJM, Crawley JTB, Lane DA, Rosendaal FR. ADAMTS13 and von Willebrand factor and the risk of myocardial infarction in men. Blood 2007; 109 (05) 1998-2000
  • 26 Andersson HM, Siegerink B, Luken BM. , et al. High VWF, low ADAMTS13, and oral contraceptives increase the risk of ischemic stroke and myocardial infarction in young women. Blood 2012; 119 (06) 1555-1560
  • 27 Lesurtel M, Graf R, Aleil B. , et al. Platelet-derived serotonin mediates liver regeneration. Science 2006; 312 (5770): 104-107
  • 28 López ML, Kieling CO, Uribe Cruz C. , et al. Platelet increases survival in a model of 90% hepatectomy in rats. Liver Int 2014; 34 (07) 1049-1056
  • 29 Murata S, Ohkohchi N, Matsuo R, Ikeda O, Myronovych A, Hoshi R. Platelets promote liver regeneration in early period after hepatectomy in mice. World J Surg 2007; 31 (04) 808-816
  • 30 Helmy A, Kishta S, Khaled E. Interrelation between peripheral platelet count and platelet activation during and after liver surgery in pigs. Blood Coagul Fibrinolysis 2010; 21 (03) 237-241
  • 31 Lisman T, Porte RJ. Mechanisms of platelet-mediated liver regeneration. Blood 2016; 128 (05) 625-629
  • 32 Alkozai EM, Nijsten MW, de Jong KP. , et al. Immediate postoperative low platelet count is associated with delayed liver function recovery after partial liver resection. Ann Surg 2010; 251 (02) 300-306
  • 33 Wang HQ, Yang J, Yang JY, Wang WT, Yan LN. Low immediate postoperative platelet count is associated with hepatic insufficiency after hepatectomy. World J Gastroenterol 2014; 20 (33) 11871-11877
  • 34 Han S, Park H-W, Song JH. , et al. Association between intraoperative platelet transfusion and early graft regeneration in living donor liver transplantation. Ann Surg 2016; 264 (06) 1065-1072
  • 35 Marietta M, Facchini L, Pedrazzi P, Busani S, Torelli G. Pathophysiology of bleeding in surgery. Transplant Proc 2006; 38 (03) 812-814
  • 36 Kleiss SF, Adelmeijer J, Meijers JCM, Porte RJ, Lisman T. A sustained decrease in plasma fibrinolytic potential following partial liver resection or pancreas resection. Thromb Res 2016; 140: 36-40
  • 37 Stahl RL, Duncan A, Hooks MA, Henderson JM, Millikan WJ, Warren WD. A hypercoagulable state follows orthotopic liver transplantation. Hepatology 1990; 12 (3 Pt 1): 553-558
  • 38 Potze W, Alkozai EM, Adelmeijer J, Porte RJ, Lisman T. Hypercoagulability following major partial liver resection - detected by thrombomodulin-modified thrombin generation testing. Aliment Pharmacol Ther 2015; 41 (02) 189-198
  • 39 Lisman T, Bakhtiari K, Pereboom ITA, Hendriks HGD, Meijers JCM, Porte RJ. Normal to increased thrombin generation in patients undergoing liver transplantation despite prolonged conventional coagulation tests. J Hepatol 2010; 52 (03) 355-361
  • 40 Mallett SV, Sugavanam A, Krzanicki DA. , et al. Alterations in coagulation following major liver resection. Anaesthesia 2016; 71 (06) 657-668
  • 41 Barton JS, Riha GM, Differding JA. , et al. Coagulopathy after a liver resection: is it over diagnosed and over treated?. HPB (Oxford) 2013; 15 (11) 865-871
  • 42 De Pietri L, Montalti R, Begliomini B. , et al. Thromboelastographic changes in liver and pancreatic cancer surgery: hypercoagulability, hypocoagulability or normocoagulability?. Eur J Anaesthesiol 2010; 27 (07) 608-616
  • 43 Cerutti E, Stratta C, Romagnoli R. , et al. Thromboelastogram monitoring in the perioperative period of hepatectomy for adult living liver donation. Liver Transpl 2004; 10 (02) 289-294
  • 44 Louis SG, Barton JS, Riha GM. , et al. The international normalized ratio overestimates coagulopathy in patients after major hepatectomy. Am J Surg 2014; 207 (05) 723-727 , discussion 727
  • 45 Krzanicki D, Sugavanam A, Mallett S. Intraoperative hypercoagulability during liver transplantation as demonstrated by thromboelastography. Liver Transpl 2013; 19 (08) 852-861
  • 46 Weinberg L, Scurrah N, Parker FC. , et al. Markers of coagulation activation after hepatic resection for cancer: evidence of sustained upregulation of coagulation. Anaesth Intensive Care 2011; 39 (05) 847-853
  • 47 Lisman T, Ariëns RAS. Alterations in fibrin structure in patients with liver diseases. Semin Thromb Hemost 2016; 42 (04) 389-396
  • 48 Tanaka KA, Key NS, Levy JH. Blood coagulation: hemostasis and thrombin regulation. Anesth Analg 2009; 108 (05) 1433-1446
  • 49 Martinez J, Palascak JE, Kwasniak D. Abnormal sialic acid content of the dysfibrinogenemia associated with liver disease. J Clin Invest 1978; 61 (02) 535-538
  • 50 Hugenholtz GCG, Macrae F, Adelmeijer J. , et al. Procoagulant changes in fibrin clot structure in patients with cirrhosis are associated with oxidative modifications of fibrinogen. J Thromb Haemost 2016; 14 (05) 1054-1066
  • 51 Groeneveld DJ, Adelmeijer J, Hugenholtz GCG, Ariëns RAS, Porte RJ, Lisman T. Ex vivo addition of fibrinogen concentrate improves the fibrin network structure in plasma samples taken during liver transplantation. J Thromb Haemost 2015; 13 (12) 2192-2201
  • 52 Arshad F, Adelmeijer J, Blokzijl H, van den Berg A, Porte R, Lisman T. Abnormal hemostatic function one year after orthotopic liver transplantation can be fully attributed to endothelial cell activation. F1000 Res 2014; 3: 103
  • 53 Porte RJ, Bontempo FA, Knot EAR, Lewis JH, Kang YG, Starzl TE. Tissue-type-plasminogen-activator-associated fibrinolysis in orthotopic liver transplantation. Transplant Proc 1989; 21 (03) 3542
  • 54 Arshad F, Lisman T, Porte RJ. Hypercoagulability as a contributor to thrombotic complications in the liver transplant recipient. Liver Int 2013; 33 (06) 820-827
  • 55 Kassis J, Hirsh J, Podor TJ. Evidence that postoperative fibrinolytic shutdown is mediated by plasma factors that stimulate endothelial cell type I plasminogen activator inhibitor biosynthesis. Blood 1992; 80 (07) 1758-1764
  • 56 Ruitenbeek K, Meijers JCM, Adelmeijer J, Hendriks HGD, Porte RJ, Lisman T. Intact thrombomodulin-mediated regulation of fibrinolysis during and after liver transplantation, despite a profoundly defective thrombomodulin-mediated regulation of coagulation. J Thromb Haemost 2010; 8 (07) 1646-1649
  • 57 Arshad F, Ickx B, van Beem RT. , et al. Prothrombin complex concentrate in the reduction of blood loss during orthotopic liver transplantation: PROTON-trial. BMC Surg 2013; 13 (01) 22
  • 58 Smyrniotis V, Kostopanagiotou G, Theodoraki K, Tsantoulas D, Contis JC. The role of central venous pressure and type of vascular control in blood loss during major liver resections. Am J Surg 2004; 187 (03) 398-402
  • 59 Jones RM, Moulton CE, Hardy KJ. Central venous pressure and its effect on blood loss during liver resection. Br J Surg 1998; 85 (08) 1058-1060
  • 60 Cleland S, Corredor C, Ye JJ, Srinivas C, McCluskey SA. Massive haemorrhage in liver transplantation: Consequences, prediction and management. World J Transplant 2016; 6 (02) 291-305
  • 61 Ricci P, Therneau TM, Malinchoc M. , et al. A prognostic model for the outcome of liver transplantation in patients with cholestatic liver disease. Hepatology 1997; 25 (03) 672-677
  • 62 de Boer MT, Christensen MC, Asmussen M. , et al. The impact of intraoperative transfusion of platelets and red blood cells on survival after liver transplantation. Anesth Analg 2008; 106 (01) 32-44
  • 63 Pereboom ITA, de Boer MT, Haagsma EB, Hendriks HGD, Lisman T, Porte RJ. Platelet transfusion during liver transplantation is associated with increased postoperative mortality due to acute lung injury. Anesth Analg 2009; 108 (04) 1083-1091
  • 64 Tzeng C-WD, Katz MHG, Fleming JB. , et al. Risk of venous thromboembolism outweighs post-hepatectomy bleeding complications: analysis of 5651 National Surgical Quality Improvement Program patients. HPB (Oxford) 2012; 14 (08) 506-513
  • 65 Turley RS, Reddy SK, Shortell CK, Clary BM, Scarborough JE. Venous thromboembolism after hepatic resection: analysis of 5,706 patients. J Gastrointest Surg 2012; 16 (09) 1705-1714
  • 66 Hayashi H, Morikawa T, Yoshida H. , et al. Safety of postoperative thromboprophylaxis after major hepatobiliary-pancreatic surgery in Japanese patients. Surg Today 2014; 44 (09) 1660-1668
  • 67 Yoshiya S, Shirabe K, Nakagawara H. , et al. Portal vein thrombosis after hepatectomy. World J Surg 2014; 38 (06) 1491-1497
  • 68 Kuboki S, Shimizu H, Ohtsuka M. , et al. Incidence, risk factors, and management options for portal vein thrombosis after hepatectomy: a 14-year, single-center experience. Am J Surg 2015; 210 (05) 878-85.e2
  • 69 Marubashi S, Sakon M, Nagano H. , et al. Effect of portal hemodynamics on liver regeneration studied in a novel portohepatic shunt rat model. Surgery 2004; 136 (05) 1028-1037
  • 70 Abshagen K, Eipel C, Vollmar B. A critical appraisal of the hemodynamic signal driving liver regeneration. Langenbecks Arch Surg 2012; 397 (04) 579-590
  • 71 Wu T-J, Dahiya D, Lee C-S. , et al. Impact of portal venous hemodynamics on indices of liver function and graft regeneration after right lobe living donor liver transplantation. Liver Transpl 2011; 17 (09) 1035-1045
  • 72 Duffy JP, Hong JC, Farmer DG. , et al. Vascular complications of orthotopic liver transplantation: experience in more than 4,200 patients. J Am Coll Surg 2009; 208 (05) 896-903 , discussion 903–905
  • 73 Ma L, Lu Q, Luo Y. Vascular complications after adult living donor liver transplantation: Evaluation with ultrasonography. World J Gastroenterol 2016; 22 (04) 1617-1626
  • 74 Bekker J, Ploem S, de Jong KP. Early hepatic artery thrombosis after liver transplantation: a systematic review of the incidence, outcome and risk factors. Am J Transplant 2009; 9 (04) 746-757
  • 75 Mourad MM, Liossis C, Gunson BK. , et al. Etiology and management of hepatic artery thrombosis after adult liver transplantation. Liver Transpl 2014; 20 (06) 713-723
  • 76 Zahr Eldeen F, Roll GR, Derosas C. , et al. Preoperative thromboelastography as a sensitive tool predicting those at risk of developing early hepatic artery thrombosis following adult liver transplantation. Transplantation 2016; 100 (11) 2382-2390
  • 77 Stine JG, Pelletier SJ, Schmitt TM, Porte RJ, Northup PG. Pre-transplant portal vein thrombosis is an independent risk factor for graft loss due to hepatic artery thrombosis in liver transplant recipients. HPB (Oxford) 2016; 18 (03) 279-286
  • 78 Jia YP, Lu Q, Gong S. , et al. Postoperative complications in patients with portal vein thrombosis after liver transplantation: evaluation with Doppler ultrasonography. World J Gastroenterol 2007; 13 (34) 4636-4640
  • 79 Werner KT, Sando S, Carey EJ. , et al. Portal vein thrombosis in patients with end stage liver disease awaiting liver transplantation: outcome of anticoagulation. Dig Dis Sci 2013; 58 (06) 1776-1780
  • 80 Emuakhagbon V, Philips P, Agopian V, Kaldas FM, Jones CM. Incidence and risk factors for deep venous thrombosis and pulmonary embolus after liver transplantation. Am J Surg 2016; 211 (04) 768-771
  • 81 Blasi A, Hernandez V, Fernandez J. , et al. Venous thrombotic events after liver transplantation (epub ahead of print). Clin Appl Thromb Hemost 2016; DOI: 10.1177/1076029616680477.
  • 82 Annamalai A, Kim I, Sundaram V, Klein A. Incidence and risk factors of deep vein thrombosis after liver transplantation. Transplant Proc 2014; 46 (10) 3564-3569
  • 83 Salami A, Qureshi W, Kuriakose P, Moonka D, Yoshida A, Abouljoud M. Frequency and predictors of venous thromboembolism in orthotopic liver transplant recipients: a single-center retrospective review. Transplant Proc 2013; 45 (01) 315-319
  • 84 Yip J, Bruno DA, Burmeister C. , et al. Deep vein thrombosis and pulmonary embolism in liver transplant patients: risks and prevention. Transplant Direct 2016; 2 (04) e68
  • 85 Peiris P, Pai S-L, Aniskevich III S. , et al. Intracardiac thrombosis during liver transplant: A 17-year single-institution study. Liver Transpl 2015; 21 (10) 1280-1285
  • 86 Xia VW, Ho JK, Nourmand H, Wray C, Busuttil RW, Steadman RH. Incidental intracardiac thromboemboli during liver transplantation: incidence, risk factors, and management. Liver Transpl 2010; 16 (12) 1421-1427
  • 87 Sakai T, Matsusaki T, Dai F. , et al. Pulmonary thromboembolism during adult liver transplantation: incidence, clinical presentation, outcome, risk factors, and diagnostic predictors. Br J Anaesth 2012; 108 (03) 469-477
  • 88 Warnaar N, Molenaar IQ, Colquhoun SD. , et al. Intraoperative pulmonary embolism and intracardiac thrombosis complicating liver transplantation: a systematic review. J Thromb Haemost 2008; 6 (02) 297-302
  • 89 Kappa SF, Gorden DL, Davidson MA, Wright JK, Guillamondegui OD. Intraoperative blood loss predicts hemorrhage-related reoperation after orthotopic liver transplantation. Am Surg 2010; 76 (09) 969-973
  • 90 Massicotte L, Lenis S, Thibeault L, Sassine M-P, Seal RF, Roy A. Effect of low central venous pressure and phlebotomy on blood product transfusion requirements during liver transplantations. Liver Transpl 2006; 12 (01) 117-123
  • 91 Li Z, Sun YM, Wu FX, Yang LQ, Lu ZJ, Yu WF. Controlled low central venous pressure reduces blood loss and transfusion requirements in hepatectomy. World J Gastroenterol 2014; 20 (01) 303-309
  • 92 Larsen JB, Hvas AM. Predictive value of whole blood and plasma coagulation tests for intra- and postoperative bleeding risk: A systematic review. Semin Thromb Hemost 2017; 43 (07) 772-805
  • 93 Kirchner C, Dirkmann D, Treckmann JW. , et al. Coagulation management with factor concentrates in liver transplantation: a single-center experience. Transfusion 2014; 54 (10 Pt 2): 2760-2768
  • 94 Chavez-Tapia NC, Alfaro-Lara R, Tellez-Avila F. , et al. Prophylactic activated recombinant factor VII in liver resection and liver transplantation: systematic review and meta-analysis. PLoS One 2011; 6 (07) e22581
  • 95 Lisman T, Porte RJ. Recombinant factor VIIa to treat severe bleeding in patients with liver disease: pitfalls and possibilities. J Hepatol 2011; 55 (04) 950-951
  • 96 Spiess BD. Transfusion of blood products affects outcome in cardiac surgery. Semin Cardiothorac Vasc Anesth 2004; 8 (04) 267-281
  • 97 Jia Q, Brown MJ, Clifford L. , et al. Prophylactic plasma transfusion for surgical patients with abnormal preoperative coagulation tests: a single-institution propensity-adjusted cohort study. Lancet Haematol 2016; 3 (03) e139-e148
  • 98 Miyamoto S, Polak WG, Geuken E. , et al. Liver transplantation with preservation of the inferior vena cava. A comparison of conventional and piggyback techniques in adults. Clin Transplant 2004; 18 (06) 686-693
  • 99 Jovine E, Mazziotti A, Grazi GL. , et al. Piggy-back versus conventional technique in liver transplantation: report of a randomized trial. Transpl Int 1997; 10 (02) 109-112
  • 100 Porte RJ, Molenaar IQ, Begliomini B. , et al; EMSALT Study Group. Aprotinin and transfusion requirements in orthotopic liver transplantation: a multicentre randomised double-blind study. Lancet 2000; 355 (9212): 1303-1309
  • 101 Findlay JY, Rettke SR, Ereth MH, Plevak DJ, Krom RAF, Kufner RP. Aprotinin reduces red blood cell transfusion in orthotopic liver transplantation: a prospective, randomized, double-blind study. Liver Transpl 2001; 7 (09) 802-807
  • 102 Dalmau A, Sabaté A, Koo M. , et al. The prophylactic use of tranexamic acid and aprotinin in orthotopic liver transplantation: a comparative study. Liver Transpl 2004; 10 (02) 279-284
  • 103 Ejaz A, Spolverato G, Kim Y. , et al. Defining incidence and risk factors of venous thromboemolism after hepatectomy. J Gastrointest Surg 2014; 18 (06) 1116-1124
  • 104 Weiss MJ, Kim Y, Ejaz A. , et al. Venous thromboembolic prophylaxis after a hepatic resection: patterns of care among liver surgeons. HPB (Oxford) 2014; 16 (10) 892-898
  • 105 Aloia TA, Geerts WH, Clary BM. , et al. Venous thromboembolism prophylaxis in liver surgery. J Gastrointest Surg 2016; 20 (01) 221-229
  • 106 Yamashita Y, Bekki Y, Imai D. , et al. Efficacy of postoperative anticoagulation therapy with enoxaparin for portal vein thrombosis after hepatic resection in patients with liver cancer. Thromb Res 2014; 134 (04) 826-831
  • 107 Tiao GM, Alonso M, Bezerra J. , et al. Liver transplantation in children younger than 1 year--the Cincinnati experience. J Pediatr Surg 2005; 40 (01) 268-273
  • 108 Zhao J-C, Lu S-C, Yan L-N. , et al. Incidence and treatment of hepatic artery complications after orthotopic liver transplantation. World J Gastroenterol 2003; 9 (12) 2853-2855
  • 109 Silva MA, Jambulingam PS, Gunson BK. , et al. Hepatic artery thrombosis following orthotopic liver transplantation: a 10-year experience from a single centre in the United Kingdom. Liver Transpl 2006; 12 (01) 146-151
  • 110 Madalosso C, de Souza Jr NF, Ilstrup DM, Wiesner RH, Krom RA. Cytomegalovirus and its association with hepatic artery thrombosis after transplantation. Transplantation 1998; 66 (03) 294-297
  • 111 Shay R, Taber D, Pilch N. , et al. Early aspirin therapy may reduce hepatic artery thrombosis in liver transplantation. Transplant Proc 2013; 45 (01) 330-334
  • 112 Vivarelli M, La Barba G, Cucchetti A. , et al. Can antiplatelet prophylaxis reduce the incidence of hepatic artery thrombosis after liver transplantation?. Liver Transpl 2007; 13 (05) 651-654
  • 113 Hsiao CY, Ho CM, Wu YM, Ho MC, Hu RH, Lee PH. Management of early hepatic artery occlusion after liver transplantation with failed rescue. World J Gastroenterol 2015; 21 (44) 12729-12734